Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06845631 · ClinicalTrials.gov registry record · NA

Retrospective-Prospective PNS Study

A NA study of Chronic Pain, sponsored by Curonix.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06845631: Recruiting NA study of Chronic Pain, sponsored by Curonix.

NCT06845631 is a NA study of Chronic Pain that is actively recruiting participants, run by Curonix. The registered enrollment target is 40 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06845631, a NA study of Chronic Pain, is actively recruiting participants, sponsored by Curonix.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective-prospective study in which 40 patients have received a permanent Freedom PNS System. Subjects presented with chronic, intractable pain of peripheral nerve origin refractory to standard medical and/or surgical treatment. A retrospective chart review will be conducted to assess baseline and follow-up parameters in patients who have received a permanent implant with the Freedom PNS system for at least 12 months. Missing data might be collected after informed consent.

Primary Outcome

A text description of the subject's pain location(s) and severity will be recorded to correlate with subject feedback. The VRS will be used to measure severity.

Conditions Studied

Interventions

  • DEVICE PNS device, observational study, no intervention during study

Study Locations (1)

Ohio

  • The Metrohealth System - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-07-01
Est. Completion 2026-12-01
Phase NA
Curonix

5 total trials

What NCT06845631 shows while recruiting

NCT06845631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which PNS device, observational study, no intervention during study is the first listed.

NCT06845631 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06845631 about?

NCT06845631 is a clinical study titled "Retrospective-Prospective PNS Study". This is a retrospective-prospective study in which 40 patients have received a permanent Freedom PNS System. Subjects presented with chronic, intractable pain of peripheral nerve origin refractory to standard medical and/or surgical treatment. A retrospective chart review will be conducted to asses...

What is the current status of trial NCT06845631?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-07-01. Estimated completion is 2026-12-01.

What conditions does trial NCT06845631 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT06845631?

The interventions under investigation include: PNS device, observational study, no intervention during study (DEVICE).

Who is sponsoring clinical trial NCT06845631?

This trial is sponsored by Curonix, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06845631 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06845631's enrollment target sits among peer trials

40 214th of 301 higher than 81 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06845631, the US trial registry maintained by the National Library of Medicine. NCT06845631 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.